Yayın:
The Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19

dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorKocaturk, İdris
dc.date.accessioned2026-01-04T17:01:11Z
dc.date.issued2022-07-01
dc.description.abstractBackground:Considering the previous evidence regarding SARS/MERS outbreaks, ıt is expected that emergent psychiatric conditions such as mood disorders, anxiety, and depression disorders may occur in survivors of COVID-19.Objectives:In this study, the effects of clinical/neurological symptoms and sociodemographic characteristics of COVID-19 patients during the infection period on the level of anxiety/depression after recovery were investigated.Methods:Firstly, the socio-demographic characteristics of the participants and their clinical/ neurological symptoms during the infection period were determined. In addition, the Beck anxiety/depression scale was administered to the participants upon discharge. Then, the odds ratio of the variables was calculated by applying the Poisson regression method to determine the predictors affecting the level of anxiety/depression.Results:In this study, the clinical/neurological symptoms and the sociodemographic characteristics affecting the level of anxiety/depression were found to be associated with adults (mean age 45-years). The number of days of hospitalization was the only clinical feature that increased both anxiety and depression levels. In addition, post-discharge sleep disorder, headache, and alcohol use were found to be predictors of increased anxiety levels. In addition, smoking, the presence of a person with COVID-19 infection in the immediate vicinity, traveling in the last month before the illness, fever, and loss of smell during the infection period was found to increase the level of depression. Moreover, asthma was the only significant comorbidity that increased the anxiety level, while diabetes was the only comorbidity that increased the depression level.Conclusion:It is expected that this study will support social-psychological intervention and have some effects on reducing depressive/anxiety symptoms, which can vary widely in adults during stressful events.
dc.description.urihttps://doi.org/10.2174/2666082218666220325105504
dc.identifier.doi10.2174/2666082218666220325105504
dc.identifier.endpage163
dc.identifier.issn2666-0822
dc.identifier.openairedoi_________::f27d4659f1592d79277f5e6451639f17
dc.identifier.orcid0000-0002-2564-991x
dc.identifier.scopus2-s2.0-105003427578
dc.identifier.startpage151
dc.identifier.urihttps://hdl.handle.net/20.500.12597/39838
dc.identifier.volume18
dc.identifier.wos000912120300006
dc.language.isoeng
dc.publisherBentham Science Publishers Ltd.
dc.relation.ispartofCurrent Psychiatry Research and Reviews
dc.subject.sdg3. Good health
dc.titleThe Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Mehmet Tahir Huyut","name":"Mehmet Tahir","surname":"Huyut","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0002-2564-991x"},"provenance":null}},{"fullName":"İdris Kocaturk","name":"İdris","surname":"Kocaturk","rank":2,"pid":null}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"FOS","value":"0302 clinical medicine"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"The Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19","subTitle":null,"descriptions":["<jats:sec><jats:title>Background:</jats:title><jats:p>Considering the previous evidence regarding SARS/MERS outbreaks, ıt is expected that emergent psychiatric conditions such as mood disorders, anxiety, and depression disorders may occur in survivors of COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Objectives:</jats:title><jats:p>In this study, the effects of clinical/neurological symptoms and sociodemographic characteristics of COVID-19 patients during the infection period on the level of anxiety/depression after recovery were investigated.</jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p>Firstly, the socio-demographic characteristics of the participants and their clinical/ neurological symptoms during the infection period were determined. In addition, the Beck anxiety/depression scale was administered to the participants upon discharge. Then, the odds ratio of the variables was calculated by applying the Poisson regression method to determine the predictors affecting the level of anxiety/depression.</jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p>In this study, the clinical/neurological symptoms and the sociodemographic characteristics affecting the level of anxiety/depression were found to be associated with adults (mean age 45-years). The number of days of hospitalization was the only clinical feature that increased both anxiety and depression levels. In addition, post-discharge sleep disorder, headache, and alcohol use were found to be predictors of increased anxiety levels. In addition, smoking, the presence of a person with COVID-19 infection in the immediate vicinity, traveling in the last month before the illness, fever, and loss of smell during the infection period was found to increase the level of depression. Moreover, asthma was the only significant comorbidity that increased the anxiety level, while diabetes was the only comorbidity that increased the depression level.</jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p>It is expected that this study will support social-psychological intervention and have some effects on reducing depressive/anxiety symptoms, which can vary widely in adults during stressful events.</jats:p></jats:sec>"],"publicationDate":"2022-07-01","publisher":"Bentham Science Publishers Ltd.","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":null,"container":{"name":"Current Psychiatry Research and Reviews","issnPrinted":"2666-0822","issnOnline":null,"issnLinking":null,"ep":"163","iss":null,"sp":"151","vol":"18","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_________::f27d4659f1592d79277f5e6451639f17","originalIds":["LiveAll1","10.2174/2666082218666220325105504","50|doiboost____|f27d4659f1592d79277f5e6451639f17"],"pids":[{"scheme":"doi","value":"10.2174/2666082218666220325105504"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":6,"influence":3.969106e-9,"popularity":7.2017596e-9,"impulse":6,"citationClass":"C5","influenceClass":"C4","impulseClass":"C4","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.2174/2666082218666220325105504"}],"type":"Article","urls":["https://doi.org/10.2174/2666082218666220325105504"],"publicationDate":"2022-07-01","refereed":"peerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Koleksiyonlar